Graded activation of the MEK1/MT1-MMP axis determines renal epithelial cell tumor phenotype. Read more about Graded activation of the MEK1/MT1-MMP axis determines renal epithelial cell tumor phenotype.
MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer. Read more about MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer.
DNA methylation profiles delineate etiologic heterogeneity and clinically important subgroups of bladder cancer. Read more about DNA methylation profiles delineate etiologic heterogeneity and clinically important subgroups of bladder cancer.
Inherited variation in immune genes and pathways and glioblastoma risk. Read more about Inherited variation in immune genes and pathways and glioblastoma risk.
Function of UDP-glucuronosyltransferase 2B17 (UGT2B17) is involved in endometrial cancer. Read more about Function of UDP-glucuronosyltransferase 2B17 (UGT2B17) is involved in endometrial cancer.
MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index. Read more about MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index.
Epigenetic inactivation of the miR-34a in hematological malignancies. Read more about Epigenetic inactivation of the miR-34a in hematological malignancies.
The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer. Read more about The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer.
Loss of Blm enhances basal cell carcinoma and rhabdomyosarcoma tumorigenesis in Ptch1+/- mice. Read more about Loss of Blm enhances basal cell carcinoma and rhabdomyosarcoma tumorigenesis in Ptch1+/- mice.
Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3. Read more about Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3.
